Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01558622 |
Date of registration:
|
16/03/2012 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Intraoperative Use of Dexketoprofen Trometamol, Pethidine Hcl, Tramadol Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication
|
Scientific title:
|
Intraoperative Use of Dexketoprofen Trometamol, Tramadol Hcl, Pethidine Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication |
Date of first enrolment:
|
March 2012 |
Target sample size:
|
72 |
Recruitment status: |
Active, not recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT01558622 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Turkey
| | | | | | | |
Contacts
|
Name:
|
GOKHAN GOKMEN, Specialist |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 18-60 years old ASA I-II patients
- Clinical diagnosis of gastroesophageal reflux patients
Exclusion Criteria:
- Allergic reactions to NSAIDs or opioid analgesics
- Body mass index exceeding 35
- Pregnancy
Age minimum:
18 Years
Age maximum:
60 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Laparoscopic Nissen Fundoplication
|
Intervention(s)
|
Drug: dexketoprofen trometamol
|
Drug: dexketoprofen trometamol + pethidine hydrochloride
|
Drug: dexketoprofen trometamol + tramadol hydrochloride
|
Drug: tramadol hydrochloride
|
Drug: pethidine hydrochloride
|
Drug: vitamin c
|
Primary Outcome(s)
|
Allergic reactions to NSAIDs or opioid analgesics, body mass index exceeding 35
[Time Frame: postoperative 2 hours]
|
Secondary ID(s)
|
KVDU 0001 GG
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|